Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "pediatric"

193 News Found

MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
Biotech | May 29, 2022

MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData

RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised


Apollo Hospitals Navi Mumbai doctors perform critical procedure to save 14-month-old baby girl
Hospitals | May 24, 2022

Apollo Hospitals Navi Mumbai doctors perform critical procedure to save 14-month-old baby girl

Successfully removed peanut from the child’s left lung through bronchoscopy


New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks
Biotech | May 23, 2022

New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks

Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment


Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions
Biotech | May 21, 2022

Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions

Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU


Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics
Medical Device | May 20, 2022

Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics

The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease


Sarclisa (isatuximab) combination provides unprecedented median progression-free survival
Biotech | May 15, 2022

Sarclisa (isatuximab) combination provides unprecedented median progression-free survival

The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19


New nirsevimab data analyses reinforce efficacy against RSV
Biotech | May 11, 2022

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose


Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City
Public Health | May 08, 2022

Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City

There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous


Novavax submits variations to expand approval in Australia and New Zealand for adolescents
Biotech | May 08, 2022

Novavax submits variations to expand approval in Australia and New Zealand for adolescents

If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand